Key facts
- It has raised $920K across 1 recorded rounds; the latest was Seed Round in Jan 2025.
- Notable investors include GrowthX Capital, Matter (Consulting Services (B2B)), Acacia Venture Capital Partners, Bold Ventures (Buffalo), Launch NY — 8 tracked in total.
- Dentite has filed 2 Form Ds with the SEC, most recently Sep 2024 ($900K sold to 34 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Dentite
Funding rounds
1 roundsAbout Dentite
Developer of an artificial intelligence medical billing software designed for creating and submitting claims to ensure reimbursement. The company's platform automates the process of submitting medical insurance claims for common dental procedures, enabling dental practices to increase their revenue and handle the entire claims process
- Sector
- Healthcare
- HQ
- Buffalo, NY, United States
- Founded
- 2022
- Employees
- 9
- Website
- dentite.com/
- Ownership
- Privately Held (backing)
Dentite doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dentite shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dentite in its N-PORT filings yet. We sweep new filings monthly.